Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Theriogenology. 2010 Sep 1;74(4):525-33. doi: 10.1016/j.theriogenology.2010.05.030. Epub 2010 Jul 7.

The use of signalling pathway inhibitors and chromatin modifiers for enhancing pluripotency.

Author information

  • 1Centre for Reproduction and Development, Monash Institute of Medical Research, Monash University, 27-31 Wright Street, Clayton VIC 3168, Australia.

Abstract

Pluripotent embryonic stem cells have been isolated from a limited number of species. The new advances with inducing pluripotency in somatic cells have resulted in the generation of pluripotent stem cells while circumventing the need for embryos. In this review we describe the main signalling pathways involved in maintaining pluripotency and inducing differentiation. Inhibition of the signalling pathways involved in differentiation enhances the derivation and cultivation of pluripotent stem cells. Furthermore, we discuss the use of chromatin modifiers to maintain an open chromatin state which is characteristic of pluripotent stem cells, to facilitate the derivation of pluripotent cell lines.

Copyright 2010 Elsevier Inc. All rights reserved.

PMID:
20615537
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk